Therapy options

This application helps to propose an appropriate fertility therapy method and to find the most suitable clinic worldwide based on the price, duration and legislative options of the treatment in various countries.

Search Results

Nothing found. Please try searching for a different keyword.

Low GnRH secretion treatments

Self therapy does not exist.

Conventional medicine does not exist.

Assisted reproduction therapy does not exist.

How can Low GnRH secretion affect fertility

In human males, after birth, the HPG axis is active until approximately 6 months of life, with gonadotropin and sex steroids concentrations peaking between 4 and 12 weeks of life. After this period, GnRH pulsatility declines and the HPG axis becomes quiescent throughout childhood. 

Onset of puberty is characterized by pulsatile GnRH release from the hypothalamus that stimulates pituitary LH secretion, which, in turn, drives testosterone production by testicular Leydig cells. GnRH also increases FSH secretion, which promotes maturation of the seminiferous tubules and spermatogonia (a type of developing sperm). 

In human females, during childhood the ovarian cycle, controlled by HPG axis, is quiescent. A growth spurt occurs at 12 years of age, and subsequently, the first menstrual cycle occurs (menarche). Menarche, induced by follicle growth and estradiol production, occurs with the initial shedding of the endometrium with subsequent bleeding. Female puberty ends when women ovulate and repeated ovulatory cycles ensure reproductive competence.

Low GnRH secretion is characterized by delayed or absent sexual development and infertility associated with inappropriately low gonadotropins (LH and FSH) and sex steroids (testosterone or estradiol). Low gonadotropins are not sufficient to trigger the production of sperms, or ovulation. Thus without reproductive cells, the pregnancy is not possible.

Pic. 1: Cleft palate
See full description